Literature DB >> 20603201

Characterization of the human PANK2 promoter.

Brenda J Polster1, Moon Y Yoon, Susan J Hayflick.   

Abstract

Pantothenate kinase 2 (PANK2) is an essential regulatory enzyme in coenzyme A biosynthesis. PANK2 mutations cause pantothenate kinase-associated neurodegeneration (PKAN), which leads to pigmentary retinopathy, progressive dystonia and other abnormalities. Two nearly identical PANK2 isoforms have been described: short PANK2 and mature PANK2, which are processed from a precursor isoform. Since the biological relevance of these isoforms remains unclear, we sought to explore their transcriptional regulation. Here we show that their regulation is distinct and describe a promoter for the short isoform of PANK2. Moreover, we identify potential regulators of PANK2 expression, including NF-Y, FOXN4 and the human heterogeneous nuclear ribonucleoprotein A/B family. These findings validate expression of the short PANK2 isoform and enable predictions about potentially deleterious sequence variants in the regulatory region of this human disease gene. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20603201      PMCID: PMC2949354          DOI: 10.1016/j.gene.2010.06.011

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  34 in total

1.  ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes.

Authors:  Ivan Ovcharenko; Marcelo A Nobrega; Gabriela G Loots; Lisa Stubbs
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity.

Authors:  Mónica Campillos; José Ramón Lamas; Miguel Angel García; María Jesús Bullido; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

3.  Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress.

Authors:  Manti Guha; Hua Pan; Ji-Kang Fang; Narayan G Avadhani
Journal:  Mol Biol Cell       Date:  2009-07-29       Impact factor: 4.138

4.  Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences.

Authors:  P Bucher
Journal:  J Mol Biol       Date:  1990-04-20       Impact factor: 5.469

5.  Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3.

Authors:  S Sinha; S N Maity; J Lu; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 6.  Human FOX gene family (Review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Oncol       Date:  2004-11       Impact factor: 5.650

7.  Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration.

Authors:  Monique A Johnson; Yien Ming Kuo; Shawn K Westaway; Susan M Parker; Katherine H L Ching; Jane Gitschier; Susan J Hayflick
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

8.  An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.

Authors:  Konstanze Hörtnagel; Holger Prokisch; Thomas Meitinger
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

9.  CCAAT/enhancer-binding protein alpha (C/EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHX1) through the interaction with DNA-bound NF-Y.

Authors:  Qin-Shi Zhu; Bin Qian; Daniel Levy
Journal:  J Biol Chem       Date:  2004-05-17       Impact factor: 5.157

10.  The CpG island searcher: a new WWW resource.

Authors:  Daiya Takai; Peter A Jones
Journal:  In Silico Biol       Date:  2003
View more
  2 in total

Review 1.  Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Authors:  Sonia Levi; Dario Finazzi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

2.  Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.

Authors:  Mónica Álvarez-Córdoba; Diana Reche-López; Paula Cilleros-Holgado; Marta Talaverón-Rey; Irene Villalón-García; Suleva Povea-Cabello; Juan M Suárez-Rivero; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; Rocío Piñero-Pérez; José A Sánchez-Alcázar
Journal:  Orphanet J Rare Dis       Date:  2022-08-09       Impact factor: 4.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.